CDEK
← All drugs Report issue

cudc-907

Small moleculeexperimental

Clinical trial activity

7 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Dec 1, 2012 (NCT01742988)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1
Mol. weight
508.56 g/mol
Lipinski Ro5
2 violation(s)
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • cudc-907
  • cudc-907
  • cudc-907
  • cudc-907

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05971758Phase 2Jan 31, 2024University of California, Los Angeles
NCT03893487Early Phase 1 (Phase 1)Jul 31, 2019Cannonball Kids' Cancer Foundation, Curis, The Pacific Pediatric Neuro-Oncology Consortium, University of California, San Francisco
NCT03002623Phase 2Dec 16, 2016National Cancer Institute (NCI)
NCT02909777Phase 1Oct 1, 2016Curis, Harvard University
NCT02674750Phase 2Jan 1, 2016Curis
NCT02307240Phase 1Nov 1, 2014Curis
NCT01742988Phase 1Dec 1, 2012Curis, The Leukemia and Lymphoma Society
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
CurisFor profit5322012
Cannonball Kids' Cancer FoundationAcademic/Hospital1012019
Harvard UniversityAcademic/Hospital1112016
National Cancer Institute (NCI)Government1112016
The Leukemia and Lymphoma SocietyAcademic/Hospital1012012
The Pacific Pediatric Neuro-Oncology ConsortiumAcademic/Hospital1012019
University of California, Los AngelesAcademic/Hospital1112024
University of California, San FranciscoAcademic/Hospital1112019
8 organizations
Page 1 / 1